BIO-RAD LABORATORIES, INC. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2010 to Q4 2014

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Bio Rad Laboratories, Inc. annual/quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2010 to Q4 2014.
  • Bio Rad Laboratories, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2014 was -$3.06M, a 106% decline year-over-year.
  • Bio Rad Laboratories, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending December 31, 2014 was -$32.9M, a 123% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -$507M, a 87.1% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$3.92B, a 203% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $3.8B, a 9.27% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2014 -$32.9M -$3.06M -$57.6M -106% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $24.7M -$78.7M -$121M -288% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $145M $10.3M -$22.2M -68.3% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $167M $38.5M +$23.5M +156% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $144M $54.5M -$14.7M -21.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $159M $41.8M -$35.3M -45.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $194M $32.6M +$26.4M +426% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $168M $15.1M -$73.6M -83% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $241M $69.2M +$23.2M +50.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $218M $77.2M +$115M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $103M $6.19M -$101M -94.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $204M $88.7M +$24M +37.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $180M $46.1M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 -$38M -$167M -129% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $107M +$110M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $64.7M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $129M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 -$2.9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.